user

Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy (vol 49, pg 61, 2022)

被引：0
|
作者：
Seerva, Riyad N. H.
Cho, Woo Cheal
Chu, Emily Y.
Marques-Piubelli, Mario L.
Ledesma, Debora A.
Richards, Kristen
Heberton, Meghan M.
Nelson, Kelly C.
Nagarajan, Priyadharsini
Torres-Cabala, Carlos A.
Prieto, Victor G.
Curry, Jonathan L.
机构：
来源：
JOURNAL OF CUTANEOUS PATHOLOGY | 2024年 / 51卷 / 07期
关键词：
D O I：
10.1111/cup.14632
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：552 / 554
页数：3
相关论文
共 50 条
  • [21] Development of VPC-70619, a Small-Molecule N-Myc Inhibitor as a Potential Therapy for Neuroendocrine Prostate Cancer
    Ton, Anh-Tien
    Foo, Jane
    Singh, Kriti
    Lee, Joseph
    Kalyta, Anastasia
    Morin, Helene
    Perez, Carl
    Ban, Fuqiang
    Leblanc, Eric
    Lallous, Nada
    Cherkasov, Artem
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (05)
  • [22] Radioiodinated Small-Molecule Tyrosine Kinase Inhibitor for HER2-Selective SPECT Imaging (vol 59, pg 1386, 2018)
    Tang
    JOURNAL OF NUCLEAR MEDICINE, 2019, 60 (03) : 438 - 438
  • [23] Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
    Kim, Byung-Hak
    Lee, Haeri
    Song, Yeonghun
    Park, Joon-Suk
    Gadhe, Changdev G.
    Choi, Jiwon
    Lee, Chung-Gi
    Pae, Ae Nim
    Kim, Sanghee
    Ye, Sang-Kyu
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (11)
  • [24] Individualized treatment of differentiated thyroid cancer: The value of surgery in combination with radioiodine imaging and therapy (vol 61, pg 87, 2022)
    Schmidt, Matthias
    Bartenstein, Peter
    Bucerius, Jan
    Dietlein, Markus
    Drzezga, Alexander
    Herrmann, Ken
    Lapa, Constantin
    Lorenz, Kerstin
    Musholt, Thomas J.
    Nagarajah, James
    Reiners, Christoph
    Sahlmann, Carsten O.
    Kreissl, Michael C.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022,
  • [25] Genetic and phenotypic analyses of human immunodeficiency virus type 1 escape from a small-molecule CCR5 inhibitor (vol 78, pg 2790, 2004)
    Kuhmann, SE
    Pugach, P
    Kunstman, KJ
    Taylor, J
    Stanfield, RL
    Snyder, A
    Strizki, JM
    Riley, J
    Baroudy, BM
    Wilson, IA
    Korber, BT
    Wolinsky, SM
    Moore, JP
    JOURNAL OF VIROLOGY, 2004, 78 (12) : 6706 - 6706
  • [26] RETRACTION: TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer (Retraction of vol 123, pg 958, 2008)
    Wang, Z.
    Song, W.
    Aboukameel, A.
    Mohammad, M.
    Wang, G.
    Banerjee, S.
    Kong, D.
    Wang, S.
    Sarkar, F. H.
    Mohammad, R. M.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 139 (09) : 2146 - 2146
  • [27] First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor (vol 15, pg 330, 2022)
    Perera, Vidya
    Wang, Zhaoqing
    Luettgen, Joseph
    Li, Danshi
    DeSouza, Mary
    Cerra, Michael
    Seiffert, Dietmar
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (04): : 1085 - 1085
  • [28] Multimodality therapy in stage III non-small cell lung cancer (vol 61, pg 1564, 1996)
    Edelman, MJ
    Gandara, DR
    Roach, M
    Benfield, JR
    ANNALS OF THORACIC SURGERY, 1996, 62 (06): : 1892 - 1892
  • [29] Identification of a small-molecule inhibitor of Stat5a/b through structure-based screen for therapy development for prostate cancer
    Liao, Z.
    Gu, L.
    Shen, F.
    Dagvadorj, A.
    Gupta, S.
    Pattabiraman, N.
    Nevalainen, M. T.
    Trabulsi, E. J.
    Gomella, L. G.
    McCue, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [30] Cancer metastasis therapeutic targets and drug discovery: emerging small-molecule protein kinase inhibitors (vol 13, pg 1, 2004)
    Sawyer
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (02) : 175 - 175
12345